106 related articles for article (PubMed ID: 15517323)
1. High sensitivity and reproducibility of immunohistochemistry with microagitation.
Nindl I; Toegl A; Sterry W; Stockfleth E
Arch Dermatol Res; 2004 Nov; 296(6):278-81. PubMed ID: 15517323
[TBL] [Abstract][Full Text] [Related]
2. Diagnosing xeroderma pigmentosum group C by immunohistochemistry.
de Feraudy S; Boubakour-Azzouz I; Fraitag S; Berneburg M; Chan L; Chew K; Clericuzio CL; Cunningham B; Tope WD; Cleaver JE
Am J Dermatopathol; 2010 Apr; 32(2):109-17. PubMed ID: 19915453
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of DNA topoisomerase I, p53, and Ki-67 in uterine carcinosarcomas.
Lee SJ; Kim HS; Kim HS; Chun YK; Hong SR; Lee JH
Hum Pathol; 2007 Aug; 38(8):1226-31. PubMed ID: 17490723
[TBL] [Abstract][Full Text] [Related]
4. Expression of P53, P27 and KI-67 in colorectal cancer patients of various ethnic origins: clinical and tissue microarray based analysis.
Cohen T; Prus D; Shia J; Abu-Wasel B; Pinto MG; Freund HR; Stojadinovic A; Grakov A; Peretz T; Nissan A
J Surg Oncol; 2008 Apr; 97(5):416-22. PubMed ID: 18286523
[TBL] [Abstract][Full Text] [Related]
5. Ki67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus.
Lörinc E; Jakobsson B; Landberg G; Veress B
Histopathology; 2005 Jun; 46(6):642-8. PubMed ID: 15910595
[TBL] [Abstract][Full Text] [Related]
6. Expression of the proliferation marker Ki-67 and of p53 tumor protein in trophoblastic tissue of preeclamptic, HELLP, and intrauterine growth-restricted pregnancies.
Jeschke U; Schiessl B; Mylonas I; Kunze S; Kuhn C; Schulze S; Friese K; Mayr D
Int J Gynecol Pathol; 2006 Oct; 25(4):354-60. PubMed ID: 16990712
[TBL] [Abstract][Full Text] [Related]
7. [Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas].
Calli C; Calli A; Pinar E; Oncel S; Demirtaşoğlu F
Kulak Burun Bogaz Ihtis Derg; 2005; 15(1-2):9-13. PubMed ID: 16340285
[TBL] [Abstract][Full Text] [Related]
8. Polyoma virus-associated cellular changes in the urine and bladder biopsy samples: a cytohistologic correlation.
Herawi M; Parwani AV; Chan T; Ali SZ; Epstein JI
Am J Surg Pathol; 2006 Mar; 30(3):345-50. PubMed ID: 16538054
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens.
Rubio J; Ramos D; López-Guerrero JA; Iborra I; Collado A; Solsona E; Almenar S; Llombart-Bosch A
Eur Urol; 2005 Nov; 48(5):745-51. PubMed ID: 16139948
[TBL] [Abstract][Full Text] [Related]
10. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
Aoyagi S; Akiyama M; Shimizu H
J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
[TBL] [Abstract][Full Text] [Related]
11. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
12. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry of p53, Bcl-2, and Ki-67 as predictors of chemosensitivity.
Itaya M; Yoshimoto J; Kojima K; Kawasaki S
Methods Mol Med; 2005; 110():213-27. PubMed ID: 15901938
[TBL] [Abstract][Full Text] [Related]
14. Tissue microarray validation: a methodologic study with special reference to lung cancer.
Karlsson C; Bodin L; Piehl-Aulin K; Karlsson MG
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2014-21. PubMed ID: 19531681
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
16. [Ki-67 and p53 expression in gastric dysplasias and cancer].
Lazarev AF; Klimachev VV; Avdalian AM; Bobrov IP; Zor'kin VT
Arkh Patol; 2006; 68(3):6-10. PubMed ID: 16830615
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
Mattila R; Alanen K; Syrjänen S
Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma.
Tucci MG; Lucarini G; Giangiacomi M; Zizzi A; Criante P; Ricotti G; Biagini G
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1220-5. PubMed ID: 17062035
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases.
Luukkaa H; Klemi P; Leivo I; Vahlberg T; Grénman R
Acta Oncol; 2006; 45(6):669-75. PubMed ID: 16938809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]